CVS Health's SilverScript Choice accounts for about 950,000 of the 1.2 million people whose stand-alone Medicare drug plans end on Dec. 31, according to a KFF analysis published Tuesday using CMS plan data and June 2026 enrollment. That is 81% of the people affected by stand-alone plan terminations for 2027, and the plan is leaving 13 of Medicare's 34 drug plan regions.
The new count turns a broad warning into a specific one. If a parent's card says SilverScript Choice and the parent lives in an affected region, the plan will not exist in that area on Jan. 1.